New cancer clinical trial: Nivolumab and BMS-986253 for Hormone-Sensitive Prostate Cancer (MAGIC-8)

Published on: September 28, 2018 at 12:00PM
Conditions:   Prostate Cancer;   Adenocarcinoma of the Prostate
Interventions:   Drug: Nivolumab;   Drug: Degarelix;   Drug: BMS-986253
Sponsors:   Charles G. Drake;   Bristol-Myers Squibb
Not yet recruiting
https://ift.tt/2NODEDo